Cardiac Fas-dependent and mitochondria-dependent apoptosis in ovariectomized rats

Maturitas

Volumn 61, Issue 3, 2008, Pages 268-277

  Lee, Shin Da ^a   Kuo, Wei Wen ^a   Ho, Ying Jui ^b   Lin, Ann Chi ^a   Tsai, Chang Hai ^c   Wang, Hsueh Fang ^d   Kuo, Chia Hua ^e   Yang, Ai Lun ^f   Huang, Chih Yang ^a,c,g   Hwang, Jin Ming ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d HUNGKUANG UNIVERSITY   (Taiwan)

^e UNIVERSITY OF TAIPEI   (Taiwan)

^f NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^g Graduate Institute of Chinese Medical Science   (Taiwan)

Author keywords

Caspase; Heart; Menopause; Oophorectomy; Ovariectomy; Type I apoptosis; Type II apoptosis

Indexed keywords

FAS ANTIGEN; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; MITOCHONDRION; NICK END LABELING; NONHUMAN; OVARIECTOMY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BODY WEIGHT; FEMALE; MENOPAUSE; MITOCHONDRIA, HEART; MYOCARDIUM; ORGAN SIZE; OVARIECTOMY; OVARY; RANDOM ALLOCATION; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 56949098140     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.07.004     Document Type: Article

References (38)

1. Skegg D.C. Hormone therapy and heart disease after the menopause. Lancet 358 (2001) 1196-1197
2. Lokkegaard E., Jovanovic Z., Heitmann B.L., Keiding N., Ottesen B., and Pedersen A.T. The association between early menopause and risk of ischaemic heart disease: influence of hormone therapy. Maturitas 53 (2006) 226-233
3. Atsma F., Bartelink M.L., Grobbee D.E., and van der Schouw Y.T. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 13 (2006) 265-279
4. Manco M., Nolfe G., Calvani M., et al. Menopause, insulin resistance, and risk factors for cardiovascular disease. Menopause 13 (2006) 809-817
5. Rossi R., Grimaldi T., Origliani G., Fantini G., Coppi F., and Modena M.G. Menopause and cardiovascular risk. Pathophysiol Haemost Thromb 32 (2002) 325-328
6. Stramba-Badiale M., Fox K.M., Priori S.G., et al. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J 27 (2006) 994-1005
7. Rautaharju P.M., Kooperberg C., Larson J.C., and LaCroix A. Electrocardiographic predictors of incident congestive heart failure and all-cause mortality in postmenopausal women: the women's health initiative. Circulation 113 (2006) 481-489
8. Narula J., Haider N., Arbustini E., and Chandrashekhar Y. Mechanisms of disease: apoptosis in heart failure-seeing hope in death. Nat Clin Pract Cardiovasc Med 3 (2006) 681-688
9. Haunstetter A., and Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 82 (1998) 1111-1129
10. Lee S.D., Chu C.H., Huang E.J., et al. Roles of insulin-like growth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation. Am J Physiol Endocrinol Metab 291 (2006) E306-E314
11. Narula J., Pandey P., Arbustini E., et al. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA 96 (1999) 8144-8149
12. Bishopric N.H., Andreka P., Slepak T., and Webster K.A. Molecular mechanisms of apoptosis in the cardiac myocyte. Curr Opin Pharmacol 1 (2001) 141-150
13. Barnhart B.C., Alappat E.C., and Peter M.E. The CD95 type I/type II model. Semin Immunol 15 (2003) 185-193
14. Bang S., Jeong E.J., Kim I.K., Jung Y.K., and Kim K.S. Fas- and tumor-necrosis factor-mediated apoptosis uses the same binding surface of FADD to trigger signal transduction. A typical model for convergent signal transduction. J Biol Chem 275 (2000) 36217-36222
15. Jeremias I., Stahnke K., and Debatin K.M. CD95/Apo-1/Fas: independent cell death induced by doxorubicin in normal cultured cardiomyocytes. Cancer Immunol Immunother 54 (2005) 655-662
16. Adams J.M., and Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26 (2001) 61-66
17. Kubasiak L.A., Hernandez O.M., Bishopric N.H., and Webster K.A. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc Natl Acad Sci USA 99 (2002) 12825-12830
18. Brown G.C., and Borutaite V. Nitric oxide, cytochrome c and mitochondria. Biochem Soc Symp 66 (1999) 17-25
19. Aggarwal B.B., Bhardwaj U., and Takada Y. Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors. Vitam Horm 67 (2004) 453-483
20. Gross A., Yin X.M., Wang K., et al. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 274 (1999) 1156-1163
21. Lee S.D., Kuo W.W., Lin J.A., et al. Effects of long-term intermittent hypoxia on mitochondrial and Fas death receptor-dependent apoptotic pathways in rat hearts. Int J Cardiol 116 (2007) 348-356
22. Lee S.D., Kuo W.W., Wu C.H., et al. Effects of short- and long-term hypobaric hypoxia on Bcl2 family in rat heart. Int J Cardiol 108 (2006) 376-384
23. Lee S.D., Tzang B.S., Kuo W.W., et al. Cardiac Fas receptor-dependent apoptotic pathway in obese Zucker rats. Obesity (Silver Spring) 15 (2007) 2407-2415
24. Lu M.C., Tzang B.S., Kuo W.W., et al. More activated cardiac mitochondrial-dependent apoptotic pathway in obese Zucker rats. Obesity (Silver Spring) 15 (2007) 2634-2642
25. Satoh M., Matter C.M., Ogita H., et al. Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. Circulation 115 (2007) 3197-3204
26. Patten R.D., Pourati I., Aronovitz M.J., et al. 17β-Estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res 95 (2004) 692-699
27. Bellino F.L. Nonprimate animal models of menopause: workshop report. Menopause 7 (2000) 14-24
28. Wu J.M., Zelinski M.B., Ingram D.K., and Ottinger M.A. Ovarian aging and menopause: current theories, hypotheses, and research models. Exp Biol Med (Maywood) 230 (2005) 818-828
29. Kritz-Silverstein D., Barrett-Connor E., and Wingard D.L. Hysterectomy, oophorectomy, and heart disease risk factors in older women. Am J Public Health 87 (1997) 676-680
30. Rocca W.A., Grossardt B.R., de Andrade M., Malkasian G.D., and Melton III L.J. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 7 (2006) 821-828
31. Johansson B.W., Kaij L., Kullander S., Lenner H.C., Svanberg L., and Astedt B. On some late effects of bilateral oophorectomy in the age range 15-30 years. Acta Obstet Gynecol Scand 54 (1975) 449-461
32. Pines A., Frenkel Y., Fisman E.Z., et al. The effect of oophorectomy and estrogen replacement therapy on Doppler derived parameters of aortic flow. Maturitas 37 (2000) 125-128
33. De Leo V., la Marca A., Agricola E., Morgante G., Mondillo S., and Setacci C. Resting ECG is modified after oophorectomy and regresses with estrogen replacement therapy in premenopausal women. Maturitas 36 (2000) 43-47
34. Brower G.L., Gardner J.D., and Janicki J.S. Gender mediated cardiac protection from adverse ventricular remodeling is abolished by ovariectomy. Mol Cell Biochem 251 (2003) 89-95
35. Hernandez I., Delgado J.L., Diaz J., et al. 17β-Estradiol prevents oxidative stress and decreases blood pressure in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 279 (2000) R1599-R1605
36. Gorodeski G.I., Yang T., Levy M.N., Goldfarb J., and Utian W.H. Effects of estrogen in vivo on coronary vascular resistance in perfused rabbit hearts. Am J Physiol 269 (1995) R1333-R1338
37. Mericli M., Nadasy G.L., Szekeres M., et al. Estrogen replacement therapy reverses changes in intramural coronary resistance arteries caused by female sex hormone depletion. Cardiovasc Res 61 (2004) 317-324
38. Kimura M., Irahara M., Yasui T., et al. The obesity in bilateral ovariectomized rats is related to a decrease in the expression of leptin receptors in the brain. Biochem Biophys Res Commun 290 (2002) 1349-1353